Endpoints: 76,849MCP servers: 32,731Payout addresses: 3,825Paid calls: 6,173Letters: 84Defects: 3,898counted 2 min ago
teppi

Endpoint · evidencePOSTapi.magentlab.com/api/calc/hfa_icos_her2

Lyon 2020 HFA-ICOS baseline cardiovascular risk before HER2-targeted therapy (trastuzumab and related agents).
Read moreLyon 2020 HFA-ICOS baseline cardiovascular risk before HER2-targeted therapy (trastuzumab and related agents). Very high, high, medium, or low from published factors plus Medium 1/2 points; expert-opinion cardiotoxicity guide <2% / 2-9% / 10-19% / >=20%. Concurrent anthracycline is High; sequential anthracycline before HER2 is Medium 1. Deterministic published classification with citation; not a treatment order. magent does not measure LVEF or biomarkers.
UNRATEDDelisted

Overview

Grade?
UNRATED
0 of 30 paid calls toward a letter
Price
$0.005 per call
Paid calls
none yet
delivery unknown until someone pays

More info

URL
https://api.magentlab.com/api/calc/hfa_icos_her2
Seen
first 2 months ago · last 32 days ago
44 free handshakes

Payment

Pays through
x402
Offered on?
Base USDC
Listed on?
Base

Handshakescomputed 17 days ago

0.407 from 21 free handshakes over 30 days · UNRATED ?

How the composite of 0.407 is made up, part by part
ComponentWeightMeasuredLower bound ?AddsShort ?Uncertain ?
livenesscosts the most
it answered at all
0.60 0.57 0.346
0.207 −0.260−0.132
latency p95
it answered as fast as its class
0.20 0.00 0.000
0.000 −0.2000
price stability
the price stayed where it was listed
0.20 1.00 1.000
0.200 00
Composite1.000.407gap to 1.000 = 0.593 · 0.460 short · 0.132 uncertain0.407−0.460−0.132

Not measured: correctness · nobody paid; honesty · nobody paid; schema conformance · no answer had a published shape to check

BURN_INFREE_TIER_ONLY
Verify it yourselfnpx teppi-check https://api.magentlab.com/api/calc/hfa_icos_her2curl -s https://api.teppi.xyz/v1/trust/cap_01M1RD9JSSTC3XXYMM8T8R01RT